economybharat.com

We Can Cover You
Click here
Facebook Youtube Instagram Linkedin
13
13

Treatment

FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer’s Disease in the US

FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer’s Disease in the US

creativebharatgroup@gmail.com January 27, 2025
Stockholm, January 27, 2025 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today...
Read More Read more about FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer’s Disease in the US
South Korea to grant precision medicine patent to Diamyd Medical for insulin antigen treatment in autoimmune diabetes

South Korea to grant precision medicine patent to Diamyd Medical for insulin antigen treatment in autoimmune diabetes

creativebharatgroup@gmail.com January 21, 2025
The South Korean Patent Office will grant a patent protecting the use of...
Read More Read more about South Korea to grant precision medicine patent to Diamyd Medical for insulin antigen treatment in autoimmune diabetes
Elicera Therapeutics’ drug candidate ELC-100 receives Orphan Drug Designation in the U.S. for the treatment of pancreatic neuroendocrine tumors

Elicera Therapeutics’ drug candidate ELC-100 receives Orphan Drug Designation in the U.S. for the treatment of pancreatic neuroendocrine tumors

creativebharatgroup@gmail.com January 13, 2025
Gothenburg, January 13, 2025 – Elicera Therapeutics AB (publ), a clinical stage cell and...
Read More Read more about Elicera Therapeutics’ drug candidate ELC-100 receives Orphan Drug Designation in the U.S. for the treatment of pancreatic neuroendocrine tumors
Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment OG_NewsReleaseCompanyLogo_93085.jpg

Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment

creativebharatgroup@gmail.com January 10, 2025
Beijing, China & Prague, Czech Republic:   Biocytogen (HKEX: 02315), a global biotech...
Read More Read more about Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment
Lundbeck announces FDA plans to host an Advisory Committee meeting on the sNDA for brexpiprazole in combination with sertraline for the treatment of adults with PTSD

Lundbeck announces FDA plans to host an Advisory Committee meeting on the sNDA for brexpiprazole in combination with sertraline for the treatment of adults with PTSD

creativebharatgroup@gmail.com January 9, 2025
H. Lundbeck A/S (Lundbeck) announces that the U.S. Food and Drug Administration...
Read More Read more about Lundbeck announces FDA plans to host an Advisory Committee meeting on the sNDA for brexpiprazole in combination with sertraline for the treatment of adults with PTSD
Pharmanovia Signs Novel Biologic In-Licensing Agreement With Lindis Biotech to Commercialise Catumaxomab for Treatment of Rare Condition, Malignant Ascites OG_NewsReleaseCompanyLogo_92535.jpg

Pharmanovia Signs Novel Biologic In-Licensing Agreement With Lindis Biotech to Commercialise Catumaxomab for Treatment of Rare Condition, Malignant Ascites

creativebharatgroup@gmail.com November 19, 2024
BASILDON, England:   Catumaxomab Received a Positive Opinion From the EMA’s Committee...
Read More Read more about Pharmanovia Signs Novel Biologic In-Licensing Agreement With Lindis Biotech to Commercialise Catumaxomab for Treatment of Rare Condition, Malignant Ascites